Construction and Performance Optimization of a Multifunctional CHP-Ti-MAO Composite Coating: Antibacterial Activity, Controlled Drug Release, and Corrosion Resistance

Titanium and its alloys are widely used in orthopedics because of their excellent mechanical properties and biocompatibility; however, their bioinert surface results in sluggish osseointegration and renders implants susceptible to bacterial infection. This study innovatively constructed a “CHP-Ti-MAO” composite coating, which aims to simultaneously improve early osseointegration and antibacterial performance. CHP micron coatings coated with hydroxyapatite (HA) and curcumin (Cur) at different PLGA concentrations (50%, 100%, and 150%) were deposited on the basis of calcium–phosphorus ceramic coatings prepared by micro-arc oxidation (MAO) following the emulsification-solvent volatilization method. It was found that increasing the concentration of PLGA can increase the particle size of the coating, enhance the hydrophilicity, and significantly improve the sustained release performance of the drug. Among them, the 100% PLGA concentration group performed the best: the drug-release half-life reached 75 h, and the corrosion current density was the lowest (9.5 × 10−9A/cm2), showing the best corrosion resistance. This group of coatings has a strong and long-term antibacterial effect on Escherichia coli, with an antibacterial rate of more than 95% at 24 h and more than 99% by day 17. The hemolysis rate of all coatings was lower than 5%, indicating good biocompatibility. This study confirmed that 100% CHP-Ti-MAO composite coating successfully solved the limitations of excessive pore size and insufficient antibacterial persistence of an MAO layer and also had excellent slow-release, corrosion resistance, and high-efficiency antibacterial capabilities, which provided an important basis for the development of a new generation of multifunctional titanium-based implants.